Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management.
Mittal R, Prasad K, Lemos JRN, Arevalo G, Hirani K.
Int J Mol Sci. 2025 Mar 5;26(5):2320. doi: 10.3390/ijms26052320.
The role of pancreatic polypeptide in pancreatic diseases.
Śliwińska-Mossoń M, Marek G, Milnerowicz H.
Adv Clin Exp Med. 2017 Dec;26(9):1447-1455. doi: 10.17219/acem/65094.
Targeting postprandial hyperglycemia.
Rendell MS, Jovanovic L.
Metabolism. 2006 Sep;55(9):1263-81. doi: 10.1016/j.metabol.2006.05.012.
Inside the Insulin Secretory Granule.
Germanos M, Gao A, Taper M, Yau B, Kebede MA.
Metabolites. 2021 Aug 5;11(8):515. doi: 10.3390/metabo11080515.
Somatostatinomas, PPomas, neurotensinomas.
Vinik AI, Strodel WE, Eckhauser FE, Moattari AR, Lloyd R.
Semin Oncol. 1987 Sep;14(3):263-81.
The influence of calcium on the basal and acetylcholine-stimulated secretion of pancreatic polypeptide.
Hermansen K, Schwartz TW.
Endocrinology. 1979 Dec;105(6):1469-74. doi: 10.1210/endo-105-6-1469.
Pathogenesis of feline diabetes mellitus.
Lutz TA, Rand JS.
Vet Clin North Am Small Anim Pract. 1995 May;25(3):527-52. doi: 10.1016/s0195-5616(95)50051-8.
Endocrine pancreatic carcinoma.
Rothmund M, Stinner B, Arnold R.
Eur J Surg Oncol. 1991 Apr;17(2):191-9.
Pancreatic beta-Cells and Type 2 Diabetes Development.
Elizabeth MM, Alarcon-Aguilar, J F, Clara OC, Escobar-Villanueva, Del Carmen M.
Curr Diabetes Rev. 2017;13(2):108-121. doi: 10.2174/1573399812666151020101222.
Neuropeptide receptors as potential pharmacological targets for obesity.
Meneguetti BT, Cardoso MH, Ribeiro CFA, Felício MR, Pinto IB, Santos NC, Carvalho CME, Franco OL.
Pharmacol Ther. 2019 Apr;196:59-78. doi: 10.1016/j.pharmthera.2018.11.002. Epub 2018 Nov 12.
